Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Analysis of Long-term (Investment) Activity Ratios

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Long-term Activity Ratios (Summary)

Medtronic PLC, long-term (investment) activity ratios

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Net fixed asset turnover
Net fixed asset turnover (including operating lease, right-of-use asset)
Total asset turnover
Equity turnover

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The long-term activity ratios reveal a divergence between the efficiency of fixed asset utilization and the overall productivity of the company's broader asset and equity base.

Fixed Asset Utilization
A consistent downward trend is observed in both the net fixed asset turnover and the turnover inclusive of operating lease right-of-use assets. The net fixed asset turnover declined from 5.77 in 2021 to 4.90 by 2026. Parallel to this, the ratio including operating leases decreased from 4.84 to 4.22 over the same period. This contraction indicates that revenue generation per unit of fixed asset investment has diminished, which may suggest significant capital expenditures that have yet to reach full revenue-generating potential.
Total Asset Turnover
Contrasting the trend in fixed assets, the total asset turnover demonstrates a steady upward trajectory. The ratio increased from 0.32 in 2021 to 0.39 in 2026. This improvement indicates an increase in the overall efficiency with which the total asset base is employed to generate sales.
Equity Turnover
Equity turnover exhibits a clear and continuous improvement, rising from 0.59 in 2021 to 0.74 in 2026. This progression reflects an enhanced ability to utilize shareholders' equity to drive revenue growth over the analyzed period.

The observed data suggests a strategic environment where overall asset and equity efficiency is improving despite a decline in the productivity of specific long-term fixed assets. The divergence implies that gains in the utilization of other asset categories or a restructuring of the balance sheet are contributing to higher total turnover and equity efficiency.



Net Fixed Asset Turnover

Medtronic PLC, net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Net sales
Property, plant, and equipment, net
Long-term Activity Ratio
Net fixed asset turnover1
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
Net Fixed Asset Turnover, Sector
Health Care Equipment & Services
Net Fixed Asset Turnover, Industry
Health Care

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Net fixed asset turnover = Net sales ÷ Property, plant, and equipment, net
= ÷ =

2 Click competitor name to see calculations.


An analysis of the long-term investment activity reveals a divergence between revenue growth and the expansion of the fixed asset base. While net sales have maintained a consistent upward trajectory over the six-year period, the efficiency with which the company utilizes its property, plant, and equipment has steadily declined.

Net Sales Performance
Net sales grew from 30,117 million USD in 2021 to 36,364 million USD by 2026. This represents a sustained increase in top-line revenue, characterized by steady growth with a notable acceleration in the final year of the period.
Fixed Asset Expansion
Net property, plant, and equipment experienced significant growth, increasing from 5,221 million USD in 2021 to 7,417 million USD in 2026. The growth rate of these net fixed assets has outpaced the growth rate of net sales, indicating an aggressive investment phase in long-term physical infrastructure.
Net Fixed Asset Turnover Trend
The net fixed asset turnover ratio peaked at 5.85 in 2022 before entering a continuous decline, reaching 4.90 by 2026. This downward trend signifies a reduction in asset efficiency, as each dollar invested in net fixed assets is generating progressively less revenue. The contraction from a high of 5.85 to 4.90 suggests that the recent capital expenditures have not yet translated into proportional increases in sales volume.

The overall trend indicates that the organization is in a phase of capacity expansion. The diminishing turnover ratio suggests that the company is currently operating with excess capacity or is investing in long-term projects that require a gestation period before contributing fully to revenue generation.



Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

Medtronic PLC, net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Net sales
 
Property, plant, and equipment, net
Operating lease right-of-use assets (classified in Other assets)
Property, plant, and equipment, net (including operating lease, right-of-use asset)
Long-term Activity Ratio
Net fixed asset turnover (including operating lease, right-of-use asset)1
Benchmarks
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector
Health Care Equipment & Services
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry
Health Care

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Net sales ÷ Property, plant, and equipment, net (including operating lease, right-of-use asset)
= ÷ =

2 Click competitor name to see calculations.


The financial performance from 2021 to 2026 exhibits a period of sustained revenue growth coupled with a more aggressive expansion of the fixed asset base, resulting in a gradual decline in asset utilization efficiency.

Net Sales Trends
A consistent upward trajectory in net sales is observed, increasing from 30,117 million USD in 2021 to 36,364 million USD by 2026. While growth remained relatively stable between 2021 and 2024, a more pronounced acceleration in revenue is evident in the projections for 2025 and 2026.
Property, Plant, and Equipment (Net) Expansion
Investment in net fixed assets, including right-of-use assets, shows a steady and uninterrupted increase throughout the period. The asset base grew from 6,219 million USD in 2021 to 8,614 million USD in 2026, representing a total increase of approximately 38.5%. The pace of investment accelerated notably after 2023.
Net Fixed Asset Turnover Analysis
The net fixed asset turnover ratio peaked at 5.06 in 2022 before entering a sustained decline, reaching 4.22 by 2026. This downward trend indicates that the growth in the fixed asset base is outpacing the growth in net sales. The reduction in the ratio suggests a diminishing marginal return on new capital investments during this timeframe, as the company is deploying more assets to generate each unit of revenue.
Operational Correlation
The divergence between the rising net sales and the falling turnover ratio confirms that the company is in a capital-intensive expansion phase. The decline from a high of 5.06 to 4.22 reflects a strategic shift toward increasing production capacity or infrastructure that has not yet reached full revenue-generating optimization.

Total Asset Turnover

Medtronic PLC, total asset turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Net sales
Total assets
Long-term Activity Ratio
Total asset turnover1
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
Total Asset Turnover, Sector
Health Care Equipment & Services
Total Asset Turnover, Industry
Health Care

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Total asset turnover = Net sales ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


The analysis reveals a steady improvement in asset utilization efficiency over the observed period. A positive correlation exists between the growth in net sales and the rising asset turnover ratio, while the total asset base remained relatively constant.

Net Sales Growth
Net sales exhibited a consistent upward trajectory, increasing from 30,117 million US dollars in April 2021 to 36,364 million US dollars by April 2026. This growth indicates a sustained expansion in revenue generation over the six-year window.
Asset Base Management
Total assets demonstrated significant stability, starting at 93,083 million US dollars in 2021 and ending at 93,028 million US dollars in 2026. The lack of substantial growth in the asset base suggests a strategic focus on optimizing existing resources rather than pursuing aggressive capital expenditure or asset acquisition.
Total Asset Turnover Efficiency
The total asset turnover ratio improved from 0.32 in 2021 to 0.39 in 2026. With the exception of a minor fluctuation in 2023, the ratio shows a progressive increase. This trend signifies that the organization is generating more revenue per dollar of assets owned, reflecting an increase in operational efficiency and a more productive utilization of the long-term investment base.


Equity Turnover

Medtronic PLC, equity turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Net sales
Shareholders’ equity
Long-term Activity Ratio
Equity turnover1
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
Equity Turnover, Sector
Health Care Equipment & Services
Equity Turnover, Industry
Health Care

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Equity turnover = Net sales ÷ Shareholders’ equity
= ÷ =

2 Click competitor name to see calculations.


The financial trajectory indicates a progressive improvement in the efficiency with which shareholders' equity is utilized to generate revenue. A consistent upward trend in the equity turnover ratio is observed over the period from 2021 to 2026, rising steadily from 0.59 to 0.74.

Net Sales Trends
Revenue demonstrates an overall growth pattern, increasing from US$ 30,117 million in 2021 to US$ 36,364 million by 2026. While a slight contraction occurred in 2023, the subsequent years reflect accelerated growth, particularly in the final year of the period.
Shareholders’ Equity Dynamics
Equity levels exhibited relative stability in the early years before entering a period of decline between 2022 and 2025, falling from US$ 52,551 million to US$ 48,024 million. A marginal recovery is observed in 2026, with equity increasing to US$ 49,463 million.
Equity Turnover Analysis
The steady increase in the equity turnover ratio is a result of the positive divergence between growing net sales and a generally contracting equity base. The progression from 0.59 to 0.74 signifies that the company is generating a higher volume of sales for every dollar of equity invested, indicating an enhancement in operational efficiency and asset productivity.